Login
Aurora Cannabis NYSE: ACB
Aurora Cannabis Inc. produces and distributes medical cannabis products.
| Name | Aurora Cannabis |
| Ticker | ACB |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
| Price | 10.16 |
| 52W Low/High | 3.83 / 25.68 |
| Market cap | 1.2 B |
| 1Y Total Return |
-57.45%
Weak |
| 1Y Volatility |
145.28%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Aurora Cannabis Inc. produces and distributes medical cannabis products.
Details
| Ticker | ACB |
| Name | Aurora Cannabis |
| ISIN | |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 1/25/21
| Close Price | 10.16 |
| 52W Low/High | 3.83 / 25.68 |
| Market cap | 1.2 B |
| 1Y Total Return |
-57.45%
Weak |
| 1Y Volatility |
145.28%
High Risk |
| Beta | 3.16 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -1,282.2% |
| Cash from Op. / Cur. Liabilities | -1.53 |
| Diluted Earnings / Share | - |
| ROE | - |
| ROIC | -70.5% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 1.9 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 0.24 |
| in Mils USD |
rolling-year up to September
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
204
|
221
|
58
|
-
|
|
| Gross Profit |
-
|
136
|
32
|
-
|
|
| R&D |
17
|
13
|
4
|
-
|
|
| EBITDA |
-2,551
|
-170
|
172
|
-
|
|
| Operating Income |
-343
|
-217
|
-156
|
-
|
|
| Net Income exc. Extra |
-
|
-
|
123
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
-
|
-3.61
|
2.45
|
-
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
2,073
|
4,280
|
3,754
|
-
|
|
| Cash, Eq & Invt ShortTerm |
123
|
189
|
375
|
-
|
|
| Total Current Assets |
324
|
449
|
490
|
-
|
|
| Total Non-Current Assets |
1,749
|
3,831
|
3,264
|
-
|
|
| Intangibles |
997
|
2,943
|
2,650
|
-
|
|
| Total Liabilities |
454
|
871
|
419
|
-
|
|
| Total Current Liabilities |
172
|
355
|
75
|
-
|
|
| Long Term Debt |
281
|
516
|
344
|
-
|
|
| Shareholder equity |
1,620
|
3,410
|
3,333
|
-
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-264
|
-166
|
-110
|
-
|
|
| Depreciation |
84
|
78
|
21
|
-
|
|
| Cash from Investing |
-175
|
-279
|
-367
|
-
|
|
| Capex |
194
|
343
|
142
|
-
|
|
| Cash from Financing |
432
|
455
|
484
|
-
|
|
| Stock Issued |
475
|
69
|
183
|
-
|
|
| Debt (LT) Issued |
-75
|
421
|
320
|
-
|
|
| Free Cash Flow |
-2,235
|
-45
|
-
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
-
|
-
|
211.2%
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
1.9
|
1.3
|
6.5
|
-
|
|
| Financial Leverage D/E |
0.24
|
0.18
|
0.07
|
-
|
|
| Return on Capital Avg |
-70.5%
|
-5.2%
|
7.6%
|
-
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available